Mariano Mazza, Giuseppe Fiorentino, Antonio M. Esquinas

Publicação: Jornal Brasileiro de Pneumologia. 2022, 48
Ano: março/abril de 2022
DOI: 10.36416/1806-3756/e20220072



We have read with great interest the study by Tomaz et al.,(1) which analyzes the clinical efficacy of a new model of a helmet-CPAP system, designated ELMOcpap, in COVID-19-related acute hypoxemic respiratory failure. We consider that that study published in the last issue
of Jornal Brasileiro de Pneumologia represents a great advance regarding CPAP therapy, showing a new model of a helmet-CPAP device, and contributes to extend the use of such devices outside ICUs. However, we believe that there are some clinical and technical aspects that should be discussed.